Search

Your search keyword '"Crozier, Cheryl"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Crozier, Cheryl" Remove constraint Author: "Crozier, Cheryl"
31 results on '"Crozier, Cheryl"'

Search Results

2. Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training

3. Pathway-based subnetworks enable cross-disease biomarker discovery.

4. Investigating the Role of SNAI1 and ZEB1 Expression in Prostate Cancer Progression and Immune Modulation of the Tumor Microenvironment

6. Evaluation of multiple transcriptomic gene risk signatures in male breast cancer

7. Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence

12. Abstract 3131: Tumour spatial heterogeneity in breast cancer and the impact on clinical management

13. Abstract PO-002: Revealing tumour spatial heterogeneity in breast cancer and the impact on clinical management

14. Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations

15. Abstract P3-08-22: The mutational landscape of cancer driver genes in matched primary ductal carcinomain situand recurrent ductal carcinomain situor recurrent invasive cancers

18. Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy–Resistant Early Breast Cancers

19. Pathway-based subnetworks enable cross-disease biomarker discovery

20. Network-Based Biomarkers Enable Cross-Disease Biomarker Discovery

21. Mechanism of the down regulation of photosynthesis by blue light in the cyanobacterium Synechocystis sp. PCC 6803

22. Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.

23. Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets.

25. Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

27. Abstract S2-01: Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer

28. Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

31. Pathway-based subnetworks enable cross-disease biomarker discovery

Catalog

Books, media, physical & digital resources